These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 18757827)

  • 1. Overexpression of vascular endothelial growth factor-B in mouse heart alters cardiac lipid metabolism and induces myocardial hypertrophy.
    Karpanen T; Bry M; Ollila HM; Seppänen-Laakso T; Liimatta E; Leskinen H; Kivelä R; Helkamaa T; Merentie M; Jeltsch M; Paavonen K; Andersson LC; Mervaala E; Hassinen IE; Ylä-Herttuala S; Oresic M; Alitalo K
    Circ Res; 2008 Oct; 103(9):1018-26. PubMed ID: 18757827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Renaissance of vascular endothelial growth factor, part B.
    Schaper W
    Circ Res; 2008 Oct; 103(9):903-4. PubMed ID: 18948625
    [No Abstract]   [Full Text] [Related]  

  • 3. Type 1 diabetic cardiomyopathy in the Akita (Ins2WT/C96Y) mouse model is characterized by lipotoxicity and diastolic dysfunction with preserved systolic function.
    Basu R; Oudit GY; Wang X; Zhang L; Ussher JR; Lopaschuk GD; Kassiri Z
    Am J Physiol Heart Circ Physiol; 2009 Dec; 297(6):H2096-108. PubMed ID: 19801494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of VEGF-B-Induced Endocardial Endothelial Cell Lineage in Physiological Versus Pathological Cardiac Hypertrophy.
    Sultan I; Ramste M; Peletier P; Hemanthakumar KA; Ramanujam D; Tirronen A; von Wright Y; Antila S; Saharinen P; Eklund L; Mervaala E; Ylä-Herttuala S; Engelhardt S; Kivelä R; Alitalo K
    Circ Res; 2024 May; 134(11):1465-1482. PubMed ID: 38655691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transgenic overexpression of platelet-derived growth factor-C in the mouse heart induces cardiac fibrosis, hypertrophy, and dilated cardiomyopathy.
    Pontén A; Li X; Thorén P; Aase K; Sjöblom T; Ostman A; Eriksson U
    Am J Pathol; 2003 Aug; 163(2):673-82. PubMed ID: 12875986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The endothelium-dependent effect of RTEF-1 in pressure overload cardiac hypertrophy: role of VEGF-B.
    Xu M; Jin Y; Song Q; Wu J; Philbrick MJ; Cully BL; An X; Guo L; Gao F; Li J
    Cardiovasc Res; 2011 May; 90(2):325-34. PubMed ID: 21169295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular endothelial growth factor-B acts as a coronary growth factor in transgenic rats without inducing angiogenesis, vascular leak, or inflammation.
    Bry M; Kivelä R; Holopainen T; Anisimov A; Tammela T; Soronen J; Silvola J; Saraste A; Jeltsch M; Korpisalo P; Carmeliet P; Lemström KB; Shibuya M; Ylä-Herttuala S; Alhonen L; Mervaala E; Andersson LC; Knuuti J; Alitalo K
    Circulation; 2010 Oct; 122(17):1725-33. PubMed ID: 20937974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelial Cells Regulate Physiological Cardiomyocyte Growth via VEGFR2-Mediated Paracrine Signaling.
    Kivelä R; Hemanthakumar KA; Vaparanta K; Robciuc M; Izumiya Y; Kidoya H; Takakura N; Peng X; Sawyer DB; Elenius K; Walsh K; Alitalo K
    Circulation; 2019 May; 139(22):2570-2584. PubMed ID: 30922063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transgenic myocardial overexpression of prokineticin receptor-2 (GPR73b) induces hypertrophy and capillary vessel leakage.
    Urayama K; Dedeoglu DB; Guilini C; Frantz S; Ertl G; Messaddeq N; Nebigil CG
    Cardiovasc Res; 2009 Jan; 81(1):28-37. PubMed ID: 18806277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reevaluation of the role of VEGF-B suggests a restricted role in the revascularization of the ischemic myocardium.
    Li X; Tjwa M; Van Hove I; Enholm B; Neven E; Paavonen K; Jeltsch M; Juan TD; Sievers RE; Chorianopoulos E; Wada H; Vanwildemeersch M; Noel A; Foidart JM; Springer ML; von Degenfeld G; Dewerchin M; Blau HM; Alitalo K; Eriksson U; Carmeliet P; Moons L
    Arterioscler Thromb Vasc Biol; 2008 Sep; 28(9):1614-20. PubMed ID: 18511699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiomyocyte-specific desmin rescue of desmin null cardiomyopathy excludes vascular involvement.
    Weisleder N; Soumaka E; Abbasi S; Taegtmeyer H; Capetanaki Y
    J Mol Cell Cardiol; 2004 Jan; 36(1):121-8. PubMed ID: 14734054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DGAT1 expression increases heart triglyceride content but ameliorates lipotoxicity.
    Liu L; Shi X; Bharadwaj KG; Ikeda S; Yamashita H; Yagyu H; Schaffer JE; Yu YH; Goldberg IJ
    J Biol Chem; 2009 Dec; 284(52):36312-36323. PubMed ID: 19778901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiomyocyte aldose reductase causes heart failure and impairs recovery from ischemia.
    Son NH; Ananthakrishnan R; Yu S; Khan RS; Jiang H; Ji R; Akashi H; Li Q; O'Shea K; Homma S; Goldberg IJ; Ramasamy R
    PLoS One; 2012; 7(9):e46549. PubMed ID: 23029549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preservation of Acyl Coenzyme A Attenuates Pathological and Metabolic Cardiac Remodeling Through Selective Lipid Trafficking.
    Goldenberg JR; Carley AN; Ji R; Zhang X; Fasano M; Schulze PC; Lewandowski ED
    Circulation; 2019 Jun; 139(24):2765-2777. PubMed ID: 30909726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VEGF-B-induced vascular growth leads to metabolic reprogramming and ischemia resistance in the heart.
    Kivelä R; Bry M; Robciuc MR; Räsänen M; Taavitsainen M; Silvola JM; Saraste A; Hulmi JJ; Anisimov A; Mäyränpää MI; Lindeman JH; Eklund L; Hellberg S; Hlushchuk R; Zhuang ZW; Simons M; Djonov V; Knuuti J; Mervaala E; Alitalo K
    EMBO Mol Med; 2014 Mar; 6(3):307-21. PubMed ID: 24448490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VEGF-B Promotes Endocardium-Derived Coronary Vessel Development and Cardiac Regeneration.
    Räsänen M; Sultan I; Paech J; Hemanthakumar KA; Yu W; He L; Tang J; Sun Y; Hlushchuk R; Huan X; Armstrong E; Khoma OZ; Mervaala E; Djonov V; Betsholtz C; Zhou B; Kivelä R; Alitalo K
    Circulation; 2021 Jan; 143(1):65-77. PubMed ID: 33203221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NF-kappaB activation is required for adaptive cardiac hypertrophy.
    Zelarayan L; Renger A; Noack C; Zafiriou MP; Gehrke C; van der Nagel R; Dietz R; de Windt L; Bergmann MW
    Cardiovasc Res; 2009 Dec; 84(3):416-24. PubMed ID: 19620128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VEGF-B taken to our hearts: specific effect of VEGF-B in myocardial ischemia.
    Claesson-Welsh L
    Arterioscler Thromb Vasc Biol; 2008 Sep; 28(9):1575-6. PubMed ID: 18716319
    [No Abstract]   [Full Text] [Related]  

  • 19. Susceptibility to Cardiac Arrhythmias and Sympathetic Nerve Growth in VEGF-B Overexpressing Myocardium.
    Lähteenvuo J; Hätinen OP; Kuivanen A; Huusko J; Paananen J; Lähteenvuo M; Nurro J; Hedman M; Hartikainen J; Laham-Karam N; Mäkinen P; Räsänen M; Alitalo K; Rosenzweig A; Ylä-Herttuala S
    Mol Ther; 2020 Jul; 28(7):1731-1740. PubMed ID: 32243833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of A kinase interacting protein 1 attenuates myocardial ischaemia/reperfusion injury but does not influence heart failure development.
    Booij HG; Yu H; De Boer RA; van de Kolk CW; van de Sluis B; Van Deursen JM; Van Gilst WH; Silljé HH; Westenbrink BD
    Cardiovasc Res; 2016 Aug; 111(3):217-26. PubMed ID: 27302402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.